Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122497814 | 12249781 | 4 | F | 2013 | 20160901 | 20160408 | 20160909 | EXP | PHHY2016MX046667 | NOVARTIS | 45.52 | YR | F | Y | 0.00000 | 20160909 | CN | COUNTRY NOT SPECIFIED | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122497814 | 12249781 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Unknown | 0.5 MG, QD | S0140 | 22527 | .5 | MG | CAPSULE | QD | |||||
| 122497814 | 12249781 | 2 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Unknown | 3 OT, QD | T1993 | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122497814 | 12249781 | 1 | Multiple sclerosis |
| 122497814 | 12249781 | 2 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122497814 | 12249781 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122497814 | 12249781 | Malaise | |
| 122497814 | 12249781 | Product use issue | |
| 122497814 | 12249781 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122497814 | 12249781 | 1 | 2013 | 0 | ||
| 122497814 | 12249781 | 2 | 2013 | 0 |